Literature DB >> 10027993

Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome.

S Stryk1, E C Siegfried, A P Knutsen.   

Abstract

Three patients with Netherton syndrome, recurrent sinopulmonary infections, and humoral immune deficiency are described. Although quantitative serum immunoglobulin levels were generally normal, two patients had selective antibody deficiency to bacterial polysaccharide antigens, one associated with IgA-IgG-2 deficiency. A third patient had an antibody deficiency to protein antigens. This is the first report, to our knowledge, that describes antibody deficiency in patients with Netherton syndrome. This finding demonstrates the importance of evaluating functional antibody responses to both protein and bacterial polysaccharide antigens and not relying on IgG subclass determination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027993     DOI: 10.1046/j.1525-1470.1999.99005.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  8 in total

Review 1.  Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.

Authors:  Brenda J Curtis; Katherine A Radek
Journal:  J Invest Dermatol       Date:  2011-09-15       Impact factor: 8.551

2.  Comèl-Netherton syndrome defined as primary immunodeficiency.

Authors:  Ellen D Renner; Dominik Hartl; Stacey Rylaarsdam; Marguerite L Young; Linda Monaco-Shawver; Gary Kleiner; M Louise Markert; E Richard Stiehm; Bernd H Belohradsky; Melissa P Upton; Troy R Torgerson; Jordan S Orange; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2009-08-14       Impact factor: 10.793

3.  Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome.

Authors:  Sukalp Muzumdar; Michael Koch; Hayley Hiebert; Andreas Bapst; Alessia Gravina; Wilhelm Bloch; Hans-Dietmar Beer; Sabine Werner; Matthias Schäfer
Journal:  Dis Model Mech       Date:  2020-06-01       Impact factor: 5.758

4.  Immune cell phenotype and functional defects in Netherton syndrome.

Authors:  Elina Eränkö; Mette Ilander; Mirja Tuomiranta; Antti Mäkitie; Tea Lassila; Anna Kreutzman; Paula Klemetti; Satu Mustjoki; Katariina Hannula-Jouppi; Annamari Ranki
Journal:  Orphanet J Rare Dis       Date:  2018-11-26       Impact factor: 4.123

Review 5.  Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases.

Authors:  Marcelo B Zani; Aquiles M Sant'Ana; Rafael C Tognato; Jair R Chagas; Luciano Puzer
Journal:  Front Med (Lausanne)       Date:  2022-03-04

Review 6.  Netherton Syndrome in Children: Management and Future Perspectives.

Authors:  Federica Barbati; Mattia Giovannini; Teresa Oranges; Lorenzo Lodi; Simona Barni; Elio Novembre; Ermanno Baldo; Mario Cristofolini; Stefano Stagi; Silvia Ricci; Francesca Mori; Cesare Filippeschi; Chiara Azzari; Giuseppe Indolfi
Journal:  Front Pediatr       Date:  2021-05-10       Impact factor: 3.418

7.  Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome.

Authors:  Laetitia Furio; Simon de Veer; Madeleine Jaillet; Anais Briot; Aurelie Robin; Celine Deraison; Alain Hovnanian
Journal:  J Exp Med       Date:  2014-02-17       Impact factor: 14.307

8.  Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency.

Authors:  Kira Stuvel; Jorn J Heeringa; Virgil A S H Dalm; Ruud W J Meijers; Els van Hoffen; Susan A M Gerritsen; Menno C van Zelm; Suzanne G M A Pasmans
Journal:  Allergy       Date:  2020-02-21       Impact factor: 13.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.